India's Dishman Carbogen Amcis drops after posting quarterly loss
** Shares of Dishman Carbogen Amcis DSHM.NS drop 10.5% to 205 rupees ** The pharmaceutical API manufacturing and drug development co posts third-quarter consol net loss of 129.7 million rupees ($1.4 mln) versus a profit of 46.3 million rupees year ago ** Third-quarter consol total income from operations up 5.5% Y/Y ** DSHM stock fell 8.5% in 2025 ($1 = 90.5025 Indian rupees) (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis